The Mononucleosis Diagnostic market report offers an excellent solution for understanding trends and opportunities within the Mononucleosis Diagnostic industry. It provides a comprehensive perspective of the market, delivering extensive market insights and analysis. This research report for the Mononucleosis Diagnostic market offers a wide range of features that are valuable for the industry, including an assessment of general market conditions, trends, preferences, key players, opportunities, and geographical analysis. Moreover, the report provides an advanced market perspective, covering product trends, marketing strategies, upcoming products, emerging geographical markets, future events, sales tactics, and customer behavior.

The Mononucleosis Diagnostic report conducts a thorough analysis and estimation of various market-related factors that are critically important for informed decision-making. It includes a competitive analysis of major market players, enabling businesses to make informed decisions to enhance their products and sales. Additionally, this Mononucleosis Diagnostic research report considers several industry verticals such as company profiles, player contact information, product specifications, geographic scope, production values, market structures, recent developments, revenue analysis, market shares, and potential sales volumes for the company.

Data Bridge Market Research analyses that the mononucleosis diagnostic market which is expected to reach at a CAGR of 5.00% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-mononucleosis-diagnostic-market

According to the Centers for Disease Control and Prevention, there were approximately 23,780 incident cases of infectious mononucleosis (IM) between 2002 and 2018, for an overall incidence rate of 104.2 cases per 100,000 person-years (p-yrs). The prevalence of IM diagnoses was highest among the youngest age groups and decreased with age. When compared to other race/ethnicity groups, non-Hispanic white service members had a higher incidence rate of IM diagnoses (123.4 per 100,000 p-yrs). The incidence of IM diagnoses among recruits was 3.4 times that of other enlisted personnel (106.0 per 100,000 p-yrs) and 5.6 times that of officers (64.7 per 100,000 p-yrs). As a result of rising incidences of infectious mononucleosis (IM), the demand for its diagnosis rises, resulting in growth.

Key Growth Drivers:

  • Technological advancements act as a promising driver

Various novel technological advancements are occurring that can diagnose the infection faster than available on the market. For instance, Roche announced in 2020 that the USFDA had approved the Cobas EBV test, the first in-vitro quantitative diagnostic test in the US for the diagnosis of EBV Epstein-Barr Virus. This is a huge success for the healthcare industry and professionals because it will make it much easier to monitor patients who are at risk from this virus because it will perform a large number of tests in a short period of time.

  • Increasing adolescent population is laying the foundation for expansion

Increasing adolescent population globally is also one of the major factor leading to growth of the market as mononucleosis is most common among teens and adults. More than half of all adolescents globally live in Asia. South Asia has nearly 350 million adolescents than any other region. It is followed by East Asia and the Pacific with over 300 million. The adolescent population of either of these regions dwarfs that of any other region in the world. According to World Health Organization (WHO) report, there are nearly 1.2 billion adolescents (10-19 years old) worldwide. In some countries, adolescents account for a quarter of the population and the number of adolescents is expected to rise through 2050, mainly in low- and middle-income countries (LMICs) where close to 90% of 10- to 19-year-olds live.

The report outlines the involvement of key players, including:

Abbott (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Weizmann Institute of Science (Israel), Biotest AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Genzyme (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), BD (U.S.), DiaSorin Molecular LLC (U.S.), Beckman Coulter, Inc. (U.S.), bioMérieux (France), Siemens (Germany), Sekisui Diagnostics (U.S.), ELITechGroup (France), Cardinal Health (U.S.), Immunostics Inc. (U.S.), Meridian Bioscience (U.S.), Thermo Fischer Scientific Inc. (U.S.)

Key Market Segmentation

Test Type (Epstein Barr Virus (EBV) Antibody Test, Monospot Test, Complete Blood Count Test), End-User (Hospitals, Laboratories, Others)

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-mononucleosis-diagnostic-market

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-prurigo-nodularis-treatment-market

https://www.databridgemarketresearch.com/reports/global-mens-health-market

https://www.databridgemarketresearch.com/reports/global-in-vitro-diagnostic-ivd-regulatory-affairs-outsourcing-market

https://www.databridgemarketresearch.com/reports/global-adrenocorticotropic-hormone-acth-market

https://www.databridgemarketresearch.com/reports/global-cystic-fibrosis-transmembrane-conductance-regulator-cftr-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com